dsm-firmenich has received a renewal of the European Union authorization for 25OHD3 from Saccharomyces cerevisiae CBS 146008 in poultry and pigs and extension for its use in ruminants, based on its Hy-D scientific dossier submitted to the European Food Safety Authority. 25OHD3 (Hy-D, the unique form from dsm-firmenich) is the main circulating form of vitamin D3 in humans and animals, and sufficient levels are associated with improvements in animal health and performance.
Benefits for ruminants
With this latest EU authorization for ruminants, farmers will be able to optimize animal lifetime performance for more sustainable farming. Hy-D enhances intestinal calcium/phosphorus absorption, critical to avoid complications during the transition period. Its role on improving Ca/P metabolism results in higher Ca/P retention throughout lactation to ensure females arrive stronger to next calving that also promotes yield increase in milk. Furthermore, Hy-D strengthens immune capacity beyond the other existing sources of vitamin D, reducing the risk of infectious diseases and metabolic disorders, thereby reducing the need for medications and promoting resilience of ruminants.
Benefits for swine and poultry
Hy-D offers significant benefits for both swine and poultry, including improved bone strength, optimized health, increased meat and egg yield, and enhanced overall quality. Proper usage of Hy-D can positively impact animal well-being and productivity.
‘We are excited about gaining authorization in the EU for Hy-D in ruminants and renewal for its use in poultry and pigs," said Emrah Mazi, head of product management special nutrients at dsm-firmenich Animal Nutrition & Health. "This milestone demonstrates the global relevance and potential of Hy-D. I am thrilled about the positive impact this approval will have in fostering animal well-being, enhanced productivity and improved sustainability."